ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
Dow Jones
40.954,48
1,85%
Euro vs US Dollar
1,09008
0,01%
Bitcoin
64.813,51
-0,06%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

  7. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI) News

ANPI

Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

Angiotech Pharmaceuticals - Common Shares (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ANPI
DatumZeitQuelleÜberschriftSymbolFirma
21/11/200820h30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
21/11/200814h30PR Newswire (US)Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture PartnersNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/11/200823h04Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
06/11/200814h00PR Newswire (US)Angiotech announces results for the third quarter ended September 30, 2008NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
28/10/200823h43Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
28/10/200821h20PR Newswire (US)Notice of conference call and webcastNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
24/10/200814h30PR Newswire (US)Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of ShareholdersNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
21/10/200800h33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
20/10/200820h51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/A)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/10/200823h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/10/200820h31PR Newswire (US)Angiotech's corporate partner, Boston Scientific, announces FDA approval of second-generation TAXUS(R) Liberte(R) drug-eluting sNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
08/10/200822h28PR Newswire (US)Angiotech's corporate partner, Boston Scientific, announces completion of clinical trial enrollment for third-generation drug-elNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
30/09/200818h47Edgar (US Regulatory)Angiotech Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
29/09/200812h01Edgar (US Regulatory)Angiotech Pharmaceuticals Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
25/09/200822h55Edgar (US Regulatory)Angiotech Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
25/09/200822h53Edgar (US Regulatory)Angiotech Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
25/09/200821h21PR Newswire (US)Angiotech's corporate partner, Boston Scientific, announces FDA approval of TAXUS(R) Express(2)(TM) Atom(TM) Stent System, firstNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
25/09/200821h07PR Newswire (US)Angiotech announces date of annual and special general meeting of shareholdersNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
23/09/200818h25Edgar (US Regulatory)Angiotech Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
23/09/200817h30MarketwiredBellwetherReport.com Analyst Opinions on HANS, ANPI, BBBY and FITBNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
23/09/200814h30PR Newswire (US)Angiotech announces the termination of its tender offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated NoNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
22/09/200814h30PR Newswire (US)Angiotech announces reorganization and cost reduction initiatives, updates financial outlookNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
12/09/200820h12Edgar (US Regulatory)Angiotech Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
12/09/200814h30PR Newswire (US)Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% SenioNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/09/200822h52PR Newswire (US)Angiotech's corporate partner, Cook Medical, completes enrollment in first international trial of drug-eluting peripheral stentNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
27/08/200815h59PR Newswire (US)BeaconEquity.com Issues Technical Trade Alerts on Active Stocks: AIDO, ANPI, LVLT, FNSR, BCON, FRPTNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
22/08/200819h00PR Newswire (US)Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% SenioNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
12/08/200814h00PR Newswire (US)Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis CatheterNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
29/07/200818h30Edgar (US Regulatory)Angiotech Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
29/07/200812h02Edgar (US Regulatory)Angiotech Pharmaceuticals Inc - Quarterly Report (10-Q)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:ANPI

Kürzlich von Ihnen besucht

AMEX
SPY
SPDR S&P 500
AMEX
XLF
Financial Select Sector
FX
EURJPY
Euro vs Yen
DBI
MDAX
MDAX
AMEX
XLE
Energy Select Sector SPDR
FX
EURUSD
Euro vs US Dollar
NYSE
NKE
Nike
COIN
ETHUSD
Ethereum
USOTC
BNPQY
BNP Paribas (QX)
TG
NOV
Novo Nordisk
NYSE
KO
Coca Cola
NYSE
JPM
JP Morgan Chase
FX
EURGBP
Euro vs Sterling
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten